New Drug Delays Type 1 Diabetes Onset by Up to 5 Years
A groundbreaking treatment called teplizumab can delay type 1 diabetes by up to five years in high-risk patients, marking the first therapy that actually modifies the disease instead of just managing symptoms. Scientists are now racing to develop additional treatments that protect insulin-producing cells before they're destroyed.